|
|
Volumn 22, Issue 2, 2012, Pages 1198-1201
|
|
In vivo evaluation of oral anti-tumoral effect of 3,4-dihydroquinazoline derivative on solid tumor
a
a
a
a
a
a
a
a
a
a
a
a
|
|
Author keywords
A549 Xenograft; Analgesic effect; Lung cancer; Oral anti tumoral activity; Solid tumor
|
|
Indexed keywords
3,4 QUINAZOLINEDIOL DERIVATIVE;
ANALGESIC AGENT;
ANTINEOPLASTIC AGENT;
CALCIUM CHANNEL BLOCKING AGENT;
KYS 05090;
PACLITAXEL;
QUINAZOLINE DERIVATIVE;
UNCLASSIFIED DRUG;
ACUTE TOXICITY;
ANALGESIC ACTIVITY;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTICLE;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG BIOAVAILABILITY;
DRUG EFFECT;
DRUG EFFICACY;
DRUG POTENCY;
HOT PLATE TEST;
IN VIVO STUDY;
MOUSE;
NONHUMAN;
SOLID TUMOR;
TUMOR VOLUME;
TUMOR XENOGRAFT;
WRITHING TEST;
ADMINISTRATION, ORAL;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CELL LINE, TUMOR;
CELL PROLIFERATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
HUMANS;
MICE;
MICE, INBRED BALB C;
MICE, INBRED ICR;
MICE, NUDE;
MOLECULAR STRUCTURE;
NEOPLASMS;
QUINAZOLINES;
STRUCTURE-ACTIVITY RELATIONSHIP;
XENOGRAFT MODEL ANTITUMOR ASSAYS;
MUS MUSCULUS;
|
|
EID: 84855659193
PISSN: 0960894X
EISSN: 14643405
Source Type: Journal
DOI: 10.1016/j.bmcl.2011.11.083 Document Type: Article |
|
Times cited : (41)
|
|
References (21)
|
